With Clovis team-up, Bristol-Myers' Opdivo eyes dynamic-duo attack on a trio of cancers

31st July 2017 Uncategorised 0

Bristol-Myers Squibb and Clovis Oncology plan to pair two of their oncology drugs in several cancer types, just days after Merck & Co. inked a multibillion-dollar partnership with AstraZeneca to test a similar drug combo.

More: With Clovis team-up, Bristol-Myers' Opdivo eyes dynamic-duo attack on a trio of cancers
Source: fierce